International Stocks Keep Crushing the S&P. This Cheap ETF Is How You Get In

Vanguard FTSE Developed Markets ETF (VEA) has outperformed the S&P 500 over the past year, returning 34% versus 27%, and is up 12% year-to-date versus 8% for SPY. The article argues the setup is improving for international developed equities due to valuation discounts, fiscal expansion abroad, stronger earnings revisions, and a softer dollar, though it notes VEA still lags over five- and ten-year horizons. VEA offers a 0.03% expense ratio and roughly 3% trailing yield, making it a low-cost way to diversify a U.S.-heavy portfolio.

Analysis

The important second-order effect is not just that developed ex-U.S. equities are catching up; it is that the market is now paying for a different macro mix. A softer dollar and stronger foreign fiscal impulse typically create a multi-quarter earnings translation tailwind, but the bigger lever is valuation compression: if dispersion between U.S. mega-cap multiples and developed ex-U.S. remains wide, even modest multiple normalization can dominate modest EPS growth. That makes the trade more about regime change in relative factor leadership than a simple mean-reversion call on regions.

Within the basket, the most interesting beneficiaries are the industrial-quality franchises with pricing power and balance-sheet flexibility, not the broad cyclicals. ASML and SAP can compound through the cycle if European capex and enterprise spend stabilize, while NVO has a separate idiosyncratic earnings path that can offset macro noise and provide defensive growth inside a value-heavy sleeve. The hidden loser is the U.S.-centric “narrow breadth” factor trade: if foreign breadth improves, U.S. defensive exposure is not the main risk — it is the second-derivative hit to mega-cap concentration and AI-adjacent multiple expansion as incremental global capital rotates into cheaper markets.

The main reversal risk is a sharp dollar squeeze higher, which would hit both translation and sentiment at the same time; that is the cleanest way to unwind this trade over a 1-3 month horizon. Over a 6-12 month horizon, the bigger threat is that foreign fiscal optimism fails to convert into better bottom-line revisions, in which case the move becomes a valuation-only rerating and loses durability. Consensus still seems too anchored to the last decade’s U.S. outperformance, so the move is probably under-owned rather than overdone, but it is likely to be choppy because the catalyst set is macro-dependent rather than purely fundamental.

Key Decisions for Investors

• Add VEA on a 3-6 month horizon as a core relative-value hedge against U.S. concentration; target a 15-25% sleeve if benchmarked to a U.S.-equity-heavy portfolio, with a stop if DXY re-accelerates materially.
• Overweight ASML vs. U.S. semi-equipment names on a 6-12 month view; the asymmetry is better if European industrial capex broadens, but trim if AI capex leadership re-concentrates in the U.S.
• Pair long VEA / short QQQ for a macro-rotation expression over the next 1-2 quarters; this isolates dollar and breadth effects while limiting outright equity beta, with the main risk being a renewed U.S. mega-cap earnings surprise.
• Initiate a tactical long NVO vs. U.S. mega-cap growth basket on any pullback; NVO gives you secular earnings quality without paying U.S. top-decile multiples, but reassess if broad risk-off drags defensives with it.
• Use FX overlay only if the dollar rally thesis is strong: hedge 25-50% of VEA foreign currency exposure rather than fully hedging, since full hedging would give up the key upside driver if the dollar continues to weaken.